US rethinks timing of biotech crackdown, easing pressure on WuXi 美國制裁提供喘息期 “藥明系”或轉攻歐洲
The latest draft of a U.S. biosecurity law would give drug companies until 2032 to cut their ties with Chinese contract suppliers, allowing WuXi companies time to focus on Europe instead. 美國參眾兩院最新《生物安全法案》草案暫定以2032年作為脫鉤最后期限，為“藥明系”的緊張局面帶來緩和空間。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.